Search

6 Mar 2024: Mobile menu. Mobile menu. Search. back. back. back. back. back. CRoSS. What is Cambridge CRoSS? CRoSS (Commercialisation of Research out of Social Sciences) is an ESRC-seeded impact acceleration programme designed to engage social innovators from

20 Mar 2024: Amanda has spun out six new companies and worked on several follow-on funding rounds and exits.

1 Feb 2024: Ananay oversees the activities of TenU, an international collaboration of leading tech transfer offices created to share effective practices in research commercialisation...

4 Jan 2024: Low-loss high-speed data transmission. Professor Mike Payne and his research team have developed a new data transmission design, based on a pair of Goubau Lines – metallic tracks or wires ... By using an appropriate antenna as a launcher and tailoring

11 Jun 2024: 11 June 2024. Lab-grown ‘mini-guts’ could help in development of new and more personalised treatments for Crohn’s disease. ... The researchers say the organoids could be used to develop and test new treatments, to see how effective they are on the

6 Jun 2024: We support social ventures originating from the University of Cambridge at every stage, from the initial idea to investment and beyond.

20 Mar 2024: In 2017-18, Amanda’s team saw a 63% increase in the number of new consultants with deals signed for 165 academics and 234 clients in that period. ... During this time, he advised businesses from early-stage translational companies to global

4 Mar 2024: If you are a member of staff or a student of the University of Cambridge with an innovative opportunity, tell us your idea confidentially.

4 Jan 2024: In 2020, there were 1.9 million new cases of colorectal cancer, which is the 3rd most common cancer worldwide. ... As a therapeutic target, LGR5 is relatively new but has been validated in a range of cancers with a therapeutic window of expression.

17 May 2024: We play a key role in the Cambridge innovation ecosystem.